myrbetriqhcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# robots.txt for https://www.myrbetriqhcp.com/ Sitemap: https://www.myrbetriqhcp.com/sitemap.xml User-agent: * Allow: | ||
Meta Tags
| Title | MYRBETRIQ® (mirabegron ER tablets) | For Healthcare |
| Description | She has places to See study data, get information on patient support options, savings, and learn more about this FDA-approved beta-3 adrenergic agonist for overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency in |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 40.121.16.193 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
myrbetriqhcp.com Valuation
|
US$28,528,735
Last updated: 2023-04-28 17:55:59
myrbetriqhcp.com has Semrush global rank of 371,005. myrbetriqhcp.com has an estimated worth of US$ 28,528,735, based on its estimated Ads revenue. myrbetriqhcp.com receives approximately 3,291,778 unique visitors each day. Its web server is located in United States, with IP address 40.121.16.193. According to SiteAdvisor, myrbetriqhcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$28,528,735 |
| Daily Ads Revenue | US$26,335 |
| Monthly Ads Revenue | US$790,027 |
| Yearly Ads Revenue | US$9,480,318 |
| Daily Unique Visitors | 219,452 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| myrbetriqhcp.com. | A | 7199 | IP: 40.121.16.193 |
| myrbetriqhcp.com. | NS | 28800 | NS Record: ns2.edgecastdns.net. |
| myrbetriqhcp.com. | NS | 28800 | NS Record: ns3.edgecastdns.net. |
| myrbetriqhcp.com. | NS | 28800 | NS Record: ns4.edgecastdns.net. |
| myrbetriqhcp.com. | NS | 28800 | NS Record: ns1.edgecastdns.net. |
| myrbetriqhcp.com. | TXT | 28800 | TXT Record: google-site-verification=vlZCHAmPo4q6dfgkWZuM84p7ay1OiQtkdNMmhEvA4v0 |
HtmlToTextCheckTime:2023-04-28 17:55:59
| MYRBETRIQ® (mirabegron ER tablets) | For Healthcare Professionals Full Prescribing Information Important Safety Information Urology Resources Patient Site Request a Rep Menu Home Mechanism of Action Efficacy Study Design Efficacy Results Adults ≥65 (PILLAR): Study Design Adults ≥65 (PILLAR): Efficacy Results Safety Safety Results Adults ≥65 (PILLAR): Safety Results Dosing & Administration Dosing Drug-to-Drug Interactions Combination Treatment MOA Combination Therapy Add-on Therapy Safety Dosing Support Patient Support Savings & Support Physician Support Full Prescribing Information Important Safety Information Urology Resources Patient Site Request a Rep Request Samples Study Design Efficacy Results Adults ≥65 (PILLAR): Study Design Adults ≥65 (PILLAR): Efficacy Results Safety Results Adults ≥65 (PILLAR): Safety Results Dosing Drug-to-Drug Interactions MOA Combination Therapy Add-on Therapy Safety Dosing Patient Resources Savings & Support Physician Resources Safety and efficacy |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 0 Content-Type: text/html; charset=UTF-8 Location: https://myrbetriqhcp.com/ Date: Thu, 21 Oct 2021 18:03:19 GMT HTTP/2 301 cache-control: no-cache,no-Store pragma: no-cache content-length: 152 content-type: text/html; charset=UTF-8 expires: -1 location: https://www.myrbetriqhcp.com/ server: Microsoft-IIS/10.0 x-powered-by: ASP.NET x-frame-options: SAMEORIGIN set-cookie: ARRAffinity=68952e5639ba0fe2ac23028de50da4e96d2caf4c4fde9c25bb017f35af4600bc;Path=/;HttpOnly;Secure;Domain=myrbetriqhcp.com set-cookie: ARRAffinitySameSite=68952e5639ba0fe2ac23028de50da4e96d2caf4c4fde9c25bb017f35af4600bc;Path=/;HttpOnly;SameSite=None;Secure;Domain=myrbetriqhcp.com date: Thu, 21 Oct 2021 18:03:19 GMT HTTP/2 200 cache-control: private,no-cache,no-Store pragma: no-cache content-length: 41835 content-type: text/html; charset=utf-8 expires: -1 server: Microsoft-IIS/10.0 set-cookie: kppid=5TcNLlqnyb0; expires=Fri, 22-Oct-2021 18:03:20 GMT; path=/; secure; HttpOnly set-cookie: ASP.NET_SessionId=ow4xxytsoc22jjytj2uiejvx; path=/; secure; HttpOnly; SameSite=Lax set-cookie: GaGuid=a7d93e72a4ec4a2199c4068195361cb0; expires=Thu, 21-Apr-2022 18:03:20 GMT; path=/; secure; HttpOnly x-aspnetmvc-version: 5.2 x-aspnet-version: 4.0.30319 request-context: appId=cid-v1:b67357b8-1362-43fc-9d8f-0083f2a71f76 access-control-expose-headers: Request-Context x-powered-by: ASP.NET x-frame-options: SAMEORIGIN set-cookie: ARRAffinity=68952e5639ba0fe2ac23028de50da4e96d2caf4c4fde9c25bb017f35af4600bc;Path=/;HttpOnly;Secure;Domain=www.myrbetriqhcp.com set-cookie: ARRAffinitySameSite=68952e5639ba0fe2ac23028de50da4e96d2caf4c4fde9c25bb017f35af4600bc;Path=/;HttpOnly;SameSite=None;Secure;Domain=www.myrbetriqhcp.com date: Thu, 21 Oct 2021 18:03:20 GMT |
myrbetriqhcp.com Whois Information
Domain Name: MYRBETRIQHCP.COM Registry Domain ID: 1754956832_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-08-05T17:55:24Z Creation Date: 2012-10-26T13:49:53Z Registry Expiry Date: 2024-10-26T13:49:53Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.EDGECASTDNS.NET Name Server: NS2.EDGECASTDNS.NET Name Server: NS3.EDGECASTDNS.NET Name Server: NS4.EDGECASTDNS.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T13:29:18Z <<< |